A new model for investigating the role of IT-based innovation in the pharmaceutical knowledge-sharing attitude

Abstract

Purpose The creation of partnerships among companies, governments and universities can improve innovation and the technological development of institutions. As innovation is a multidimensional concept, more nuanced research is needed to identify, which dimensions of innovation firms should focus on them. This paper aims to investigate the influence of attitude to knowledge sharing (KS) factors, learning organization and creativity on the innovation in marketing biotechnology firms. So, the purpose of this paper is to examine the influence of learning organization, attitude to KS, creativity, information technology (IT) acceptance, KS culture and trust on the innovation by presenting a new framework and a model. Design/methodology/approach The structural equation modeling technique is used to examine the reliability and validity of the measurement of the provided model. Data were collected by questionnaires. A case study was carried out in 100 marketing biotechnology firms in the Tehran of Iran. In this paper, smart partial least squares 2.0 was used to evaluate the measurement. Findings The result showed that all hypotheses of this research are proved. Also, the results have shown that the attitude to KS, learning organization and creativity affect the innovation in marketing biotechnology firms. As an overall result, the managers should create an enhanced knowledge bank to increase and encourage the KS among employees, thus creating and enhancing innovation in organizations. Also, the results have shown that marketing shortages were mostly connected to access to human resources with related management and marketing experiences and were mainly felt by firms introducing discontinuous novelties. Research limitations/implications The main limitation of this paper is that the sample was retrieved from 384 employees in 100 marketing biotechnology institutions. The larger number of samples can yield better results. Next, even though the respondents’ profiles indicated a high probability of them being cognizant of their organization’s efforts in inter-firm KS, learning, creativity and innovation with three or four respondent from each organization answering all questions for such complicated issues always poses the risk of measurement bias and inaccuracy. An ideal situation for future studies would be to pool and compare multiple respondents from the same organization to obtain a more comprehensive firm-level measurement. In addition, this study only surveyed and sampled biotech marketing companies in Iran. Therefore, the model should be examined using samples from other countries because the varieties of culture could have an impact on employee apprehensions. So, future researchers can test the measurement instrument in different countries and/or conduct large multi-national comparisons. Practical implications Successful marketing strategies depend very much on an organization’s ability to implement them. This paper provides an excellent study about the future of pharmaceutical KS and shows that innovation paths are linked with local and temporary occasions. Also, the results of this study provide valuable information in formulating marketing biotechnology programs. It is essential to study both economics and innovation for students and academics. The results also suggested that policies to increase economic research will also increase innovation. They could contain the consolidation of the legal framework and institutional resources for public organizations to protect intellectual properties. In general, for successful implementation of strategies an organization has to integrate KS, processes and IT. Social implications The paper identifies the most critical factors in the innovation process of enterprizes in marketing biotechnology institutions. The implications derived from this study can shed new light upon policy-making both at the level of governance and in the management practice in Iran’s marketing biotechnology industry. Also, the paper increases understanding of the innovation process in Iran marketing biotechnology companies. This study contributes to innovating management research by offering a set of legal and dependable operational measures. These measures can help academics in theory analysis. Originality/value This is the first attempt examining the role of the learning organization, creativity and attitude to KS as a key contingency factor in innovation in Iran marketing biotechnology firms, an issue whose understanding is still developing in the literature. The paper adds to the body of knowledge by allowing better understanding the attitude toward KS and the influence of KS, learning and creativity on innovation. Previous studies did not investigate the KS in marketing biotechnology firms deeply, but, the present paper permits a more complete view on this topic. The guidelines are provided for the top directors to promote KS and innovation according to the research results. From a managerial point of view some critical elements, which are important for the success of KS and application of these elements for progressing institutional guidelines to develop KS, are considered. Theoretical foundations can be extracted from this study, and these foundations can be implemented to investigate connection in KS elements such as feasibilities processes and institution initiative abilities. So, the results could be suitable to managers when arranging an organization and shaping its culture to improve knowledge management.

Unleashing the mechanism between affect-based trust and employee creativity: a knowledge sharing perspective

“…EC is essential for an organizational long-term survival (Alshwayat et al , 2021). Therefore, past studies have highlighted the need to focus EC in all type of organizations including manufacturing (Hui et al , 2020; Kmieciak, 2020; Lee et al , 2020) and non-manufacturing organizations (Chen et al , 2020; Anser et al , 2020), banks (De Clercq and Pereira, 2020), information technology (Thuan and Thanh, 2020), high-technology firms (Dong et al , 2016) and biotechnology companies (Liu and Zeinaly, 2020). Therefore, this study collected data from the employees working in various organizations of Pakistan.…”

“…Thus, considering the long-term benefits of EC and future directions of Kmieciak (2020), this study focused on ABT as a predictor of EC. Second, although, Liu and Zeinaly (2020) have identified the intervening role of KS between trust and employees' innovative behavior, whereas Zeb et al (2019) have noted KS as an important predictor of EC. Still, the literature on the mechanism between trust and EC is scant and need further attention (Zhang et al, 2020;Lee, 2021); therefore, this study proposes KS as an intervening variable between ABT and EC.…”

A theoretical framework for identifying appropriate marketing approaches across the product development life cycle for biomedical science SMEs

“…A study by Kremer et al (2019) noted that research companies also focus on knowledge sharing (KS). KS is a method where team members share their knowledge between people, teams and institutions; this can include knowledge capture, team briefings, publishing in academic conferences and journals et cetera (Kremer et al, 2019;Liu and Zeinaly, 2021). This method is essential for organisations where they can improve their efficiency and reduce training needs.…”

“…KS provides creativity and innovation, which improves culture and character within the firm (Kremer et al, 2019). It is also noted that the managers should create an improved knowledge bank to increase and encourage KS among employees, thus creating and enhancing innovation in organisations (Liu and Zeinaly, 2021). KS is a key success factor that leads to creativity and innovation, in which employees get the most out of the accumulated knowledge in an organisation.…”

“…Ipe (2003) notes that an organisation's ability to leverage its knowledge is highly dependent on people who create, share and use the knowledge. KS has a positive effect on innovation as it increases the marketing capability of biomedical science firms to a higher level to achieve their target aims, learning new techniques, protecting valuable research, creating core capabilities, initiating new situations and creating productivity providing competitive merit for an institution (Liu and Zeinaly, 2021).…”